Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Eilis Dowd"'
Publikováno v:
International Journal of Cell Biology, Vol 2010 (2010)
6-hydroxydopamine (6-OHDA) is a selective neurotoxin that is widely used to investigate cell death and protective strategies in models of Parkinson's disease. Here, we investigated the effects of the endogenous cannabinoid, anandamide, on 6-OHDA-indu
Externí odkaz:
https://doaj.org/article/ec1acc946a344650a164e4ffcb1591e5
Autor:
Francesco Gubinelli, Sílvia Cabré Giménez, Veronica Alamilla Marroquin, Marie-Claude Gaillard, Eilis Dowd, Emmanuel Brouillet, Julien Flament
Publikováno v:
PHysiopathology Of Parkinsons DisEaSe (HOPE 2018), Lille, April 2018
Parkinson’s Disease (PD) is the second most common neurodegenerative disease, affecting 0.3% of general population, with an increasing rate of 1 to 2% in persons over 65 1. At the moment the only available pharmacological treatment (L-Dopa) focuses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3df945b527ae058bf9ec336148aaed16
https://doi.org/10.5281/zenodo.2537684
https://doi.org/10.5281/zenodo.2537684
Autor:
Rachel Kelly, Alexis-Pierre Bemelmans, Charlène Joséphine, Emmanuel Brouillet, Declan P. McKernan, Eilís Dowd
Publikováno v:
Molecules, Vol 27, Iss 2, p 507 (2022)
Since the discovery of α-synuclein as the major component in Lewy bodies, research into this protein in the context of Parkinson’s disease pathology has been exponential. Cannabinoids are being investigated as potential therapies for Parkinson’s
Externí odkaz:
https://doaj.org/article/34cd1aa5c0a6490e97b46759ce7c1d82
Autor:
Rachel Kelly, Andrew G. Cairns, Jörgen Ådén, Fredrik Almqvist, Alexis-Pierre Bemelmans, Emmanuel Brouillet, Tommy Patton, Declan P. McKernan, Eilís Dowd
Publikováno v:
Biomolecules, Vol 11, Iss 11, p 1685 (2021)
Animal models of Parkinson’s disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the most relevant models of the human condition. However, although highly
Externí odkaz:
https://doaj.org/article/c447a4e33b7344ddb7f816064af2a6e0
Publikováno v:
International Journal of Cell Biology; 2010, Vol. 2010, p1-10, 10p, 1 Diagram, 4 Graphs
Publikováno v:
Molecules, Vol 25, Iss 3, p 453 (2020)
Parkinson’s disease is a neurodegenerative disorder, the motor symptoms of which are associated classically with Lewy body formation and nigrostriatal degeneration. Neuroinflammation has been implicated in the progression of this disease, by which
Externí odkaz:
https://doaj.org/article/f7fa885fa0cf49cebaf62ffd8cdb7531
Autor:
Niamh Moriarty, Eilís Dowd
Publikováno v:
Neural Regeneration Research, Vol 13, Iss 7, Pp 1187-1188 (2018)
Externí odkaz:
https://doaj.org/article/1fa6065d966a46598a0cac3b212c6e51
Autor:
Francesco Gubinelli, Sílvia Cabré Giménez, Veronica Alamilla Marroquin, Marie-Claude Gaillard, Eilis Dowd, Emmanuel Brouillet, Julien Flament
Parkinson’s Disease (PD) is the second most common neurodegenerative disease, affecting 0.3% of general population, with an increasing rate of 1 to 2% in persons over 65 1. At the moment the only available pharmacological treatment (L-Dopa) focuses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c46ec9d523b72e00190b33e097c87d4
Autor:
Francesco Gubinelli, Sílvia Cabré Giménez, Veronica Alamilla Marroquin, Marie-Claude Gaillard, Eilis Dowd, Emmanuel Brouillet, Julien Flament
Parkinson’s Disease (PD) is the second most common neurodegenerative disease, affecting 0.3% of general population, with an increasing rate of 1 to 2% in persons over 65 1. At the moment the only available pharmacological treatment (L-Dopa) focuses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3df945b527ae058bf9ec336148aaed16